Invivyd Announces CEO Transition
GlobeNewswire
Jeremy Gowler appointed Interim CEO
WALTHAM, Mass., April 12, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a..
Pre-exposure prophylaxis
News and Video Search Results
News coverage
-
Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups
Business Wire
-
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
-
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire
-
News24 | PrEP pills are available in SA - but barriers are hindering uptake
News24
0 shares
1 views
You might like
Pre-exposure prophylaxis media coverage
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
GlobeNewswire
· Analysis of secondary endpoint of symptomatic COVID-19 events in CANOPY is unrelated to regulatory filing or review, but may be..
-
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
GlobeNewswire
-
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
PR Newswire Asia
-
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
GlobeNewswire
-
Terrence Higgins Trust says HIV drug should be available online, in pharmacies and from GPs
Nottingham Post
Advertisement
More coverage
Human Immunodeficiency Virus (HIV) Therapeutics Forecast and Market Analysis to 2030 -Persistence Market Research
GlobeNewswire
HIV therapeutics, crucial for combating the virus and preventing AIDS, are expected to be led by North America, holding the largest..
-
Herpes Simplex Virus Treatment Market is set to Reach US$ 2.68 billion at a CAGR of 5.6% from the forecast period 2023 to 2031 | Growth Plus Reports
GlobeNewswire
-
Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities
GlobeNewswire
-
Gilead's Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
Accesswire
-
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
GlobeNewswire